Alveo Technologies

With more than 20 years of experience in strategic business development for medical device and diagnostic companies ranging from start-ups to mature global corporations, Erik most recently served as Vice President of Business Development at Atonarp, Inc., and previously as Head of Business Development for Thermo Fisher Scientific, and previously as Senior Vice President of Business Development and Product Management at Mesa Biotech prior to its acquisition by Thermo Fisher. Slava Elagin brings to Alveo more than 20 years of experience in the in vitro diagnostics and medical devices industry. Food & Drug Administration clearances and commercialization and is the author on 12 U.S. John, a seasoned Manufacturing Operations Leader, spans small startups to industry giants like Flextronics, Mars Petcare, and Tesla Motors, showcasing expertise in management, manufacturing, and logistics. Kevin Gunning oversees Alveo’s Quality Management System and holds more than 25 years of experience working in the medical device, pharmaceutical, biotechnology and clinical laboratory industries. Mary McFillin is a senior global product marketing manager with extensive experience in the point-of-care diagnostics industry, leading strategy, development and support of in vitro diagnostics medical devices throughout the product life cycle. As a senior product management executive, Mary leads Alveo’s strategic marketing and target market development. Matthew Marsh has nearly 25 years of experience driving growth and value creation for customers, employees and shareholders.